BackAstria Therapeutics Overview

Astria Therapeutics Selling, General & Admin

Selling, General & Admin expenses for ATXS.

Quarterly SG&A Expenses

$10.66M
↑ 25.36% YoY

As of Sep 30, 2025

Annual SG&A Expenses (TTM)

$39.17M
↑ 21.08% YoY

Trailing 12 months ending Sep 30, 2025

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin